These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33323155)

  • 1. Rational allocation of coronavirus disease 2019 (COVID-19) vaccines to healthcare personnel and patients: A role for antimicrobial stewardship programs?
    Nori P; Patel PK; Stevens MP
    Infect Control Hosp Epidemiol; 2022 Feb; 43(2):263-265. PubMed ID: 33323155
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications.
    Pierce J; Stevens MP
    Int J Infect Dis; 2021 Dec; 113():103-108. PubMed ID: 34624517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic distribution of coronavirus disease 2019 (COVID-19) guidelines: A potential tool for antimicrobial stewardship programs.
    Pierce J; Kim J; Deja EN; Lee K; Doll M; Bearman G; Stevens MP
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1737-1738. PubMed ID: 34548124
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the strategies implemented by an antimicrobial stewardship program on the antibiotic consumption in the coronavirus disease 2019 (COVID-19) pandemic.
    Murgadella-Sancho A; Coloma-Conde A; Oriol-Bermúdez I
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1292-1293. PubMed ID: 34016214
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
    De Waele JJ; Derde L; Bassetti M
    Intensive Care Med; 2021 Jan; 47(1):104-106. PubMed ID: 33068116
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.
    Swift MD; Breeher LE; Tande AJ; Tommaso CP; Hainy CM; Chu H; Murad MH; Berbari EF; Virk A
    Clin Infect Dis; 2021 Sep; 73(6):e1376-e1379. PubMed ID: 33900384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19: don't neglect antimicrobial stewardship principles!
    Huttner BD; Catho G; Pano-Pardo JR; Pulcini C; Schouten J
    Clin Microbiol Infect; 2020 Jul; 26(7):808-810. PubMed ID: 32360446
    [No Abstract]   [Full Text] [Related]  

  • 8. Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?
    Chibabhai V; Duse AG; Perovic O; Richards GA
    S Afr Med J; 2020 Jun; 110(7):572-573. PubMed ID: 32880323
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19.
    Stevenson DR; Sahemey M; Cevallos Morales J; Martín-Lázaro J; Buchanan R; Serafino Wani R
    Clin Infect Dis; 2021 Jun; 72(11):e926. PubMed ID: 33038229
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Antimicrobial resistance and stewardship in the COVID-19 era.
    Kakkar AK; Shafiq N
    Front Public Health; 2024; 12():1398981. PubMed ID: 38751594
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities.
    Kubin CJ; Loo AS; Cheng J; Nelson B; Mehta M; Mazur S; So W; Calfee DP; Singh HK; Greendyke WG; Simon MS; Furuya EY
    Am J Health Syst Pharm; 2021 Mar; 78(8):743-750. PubMed ID: 33543233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus disease 2019 (COVID-19) and antibiotic stewardship: Using a systems engineering approach to maintain patient safety.
    Keating JA; McKinley L; Safdar N
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1416-1418. PubMed ID: 33040756
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
    Furukawa D; Graber CJ
    Clin Infect Dis; 2021 May; 72(10):e542-e544. PubMed ID: 32857832
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic.
    Martin E; Philbin M; Hughes G; Bergin C; Talento AF
    J Antimicrob Chemother; 2021 Jan; 76(1):272-275. PubMed ID: 33011763
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: Lessons from the "dynamic zero-COVID policy" in mainland China.
    Yang G; Ren Z; Zou Y; Xu Q; Li S; Pan L; Zha L
    J Infect; 2022 May; 84(5):e39-e41. PubMed ID: 35314267
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 will further exacerbate global antimicrobial resistance.
    Yam ELY
    J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32539142
    [No Abstract]   [Full Text] [Related]  

  • 17. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
    Monnet DL; Harbarth S
    Euro Surveill; 2020 Nov; 25(45):. PubMed ID: 33183403
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrating antibiotic stewardship and infection prevention and control programs using a team science approach.
    Knobloch MJ; McKinley L; Keating J; Safdar N
    Am J Infect Control; 2021 Aug; 49(8):1072-1074. PubMed ID: 33524453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).
    Liew Y; Lee WHL; Tan L; Kwa ALH; Thien SY; Cherng BPZ; Chung SJ
    Int J Antimicrob Agents; 2020 Nov; 56(5):106145. PubMed ID: 32860880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.